Početna › Folikularni limfom › Washington
Kliničke studije za Folikularni limfom u državi Washington
19 studija za Folikularni limfom traži sudionike na lokacijama u državi Washington.
Gradovi u državi Washington
Službeni tekst studije (engleski)
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, Seattle
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06542250A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Fred Hutchinson Cancer Research Center, Seattle
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05006716A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Swedish Cancer Institute (SCI), Seattle
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Fred Hutchinson Cancer Research Center, Seattle
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Tacoma
U tijeku regrutacijaFaza 3
Od 18 do 130 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06549595Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Northwest Medical Specialties, Tacoma
U tijeku regrutacijaFaza 3
Od 12 do 100 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT06784752SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Fred Hutch Cancer Center, Seattle
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT05303519Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 27. kol 2026. · NCT06442475A Study of ARC-02 in B-cell NHL
- Summit Cancer Centers - North Spokane, Spokane
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT07691606This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
- Fred Hutchinson Cancer Center, Seattle
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT07121946Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 4. lip 2026. · NCT06948786Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
6 Months · Oba spola · Ažurirano 29. svi 2026. · NCT04195633A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Local Institution - 0143, Vancouver
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 20. svi 2026. · NCT06911502Study of SGR-1505 in Mature B-Cell Neoplasms
- Fred Hutchinson Cancer Center, Seattle
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 13. velj 2026. · NCT05544019A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
- University of Washington-Seattle Cancer Care Alliance, Seattle
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. sij 2026. · NCT04669171SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Seattle
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- Swedish Cancer Institute, Seattle
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2025. · NCT05780034Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
- University of Washington Medical Center, Seattle
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 23. velj 2021. · NCT02537769Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.